Guangzhou Kingmed Diagnostics Group Co., Ltd.

Total Valuation

Guangzhou Kingmed Diagnostics Group Co., Ltd. carries a market capitalization of 11.01B, placing it among publicly traded companies globally. Its enterprise value stands at 11.94B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Guangzhou Kingmed Diagnostics Group Co., Ltd. currently has 463.26M shares outstanding.

Valuation Ratios

Guangzhou Kingmed Diagnostics Group Co., Ltd. trades at a trailing price-to-earnings ratio of 26.69. The price-to-sales ratio is 2.10, and the price-to-book ratio stands at 2.45.

Enterprise Valuation

On an enterprise value basis, Guangzhou Kingmed Diagnostics Group Co., Ltd. trades at an EV/EBITDA multiple of 49.63 and an EV/FCF ratio of 27.87. The EV/Sales ratio of 1.89 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 49.63 provides insight into valuation relative to core operating earnings.

Financial Position

Guangzhou Kingmed Diagnostics Group Co., Ltd. maintains a current ratio of 3.09, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 11.12, indicating elevated leverage, while an interest coverage ratio of 14.06 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Guangzhou Kingmed Diagnostics Group Co., Ltd.'s stock has declined approximately -14.80287% over the past 52 weeks. The 50-day moving average sits at 25.56, while the 200-day moving average is 28.45.

Income Statement

Over the trailing twelve months, Guangzhou Kingmed Diagnostics Group Co., Ltd. generated 6.31B in revenue and converted that into -555.70M in net income, yielding earnings per share of -1.28. EBITDA reached 240.66M, while operating income came in at 240.66M.

Balance Sheet

Guangzhou Kingmed Diagnostics Group Co., Ltd. holds 2.18B in cash and equivalents against 772.32M in total debt, resulting in a net debt position of -1.67B. Total book value stands at 5.39B, with working capital of 4.53B providing operational flexibility.

Cash Flow

After subtracting -412.84M in capital expenditures, free cash flow totaled -412.84M - equivalent to -0.89 per share.

Margins

Guangzhou Kingmed Diagnostics Group Co., Ltd. operates with a gross margin of 32.53, reflecting its pricing power and cost economics. The operating margin of 3.82 and net profit margin of -8.81 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -65.88 indicates the proportion of earnings distributed to shareholders.

Scores

Guangzhou Kingmed Diagnostics Group Co., Ltd. posts an Altman Z-Score of 4.83, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.